WASHINGTON – The Office of the United States Trade Representative today announced that it is seeking public comments on whether to further extend COVID related product exclusions in the Section 301 Investigation of China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation.
The exclusions, which cover 81 medical-care products, were initially granted in December 2020, and were previously scheduled to expire on February 28, 2023.
As explained in a formal notice, USTR is requesting public comments on whether to extend particular exclusions for COVID-related products for up to six months. The notice also announces an interim 75-day extension of the exclusions, through May 15, 2023, to allow for consideration of public comments.
###
